Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.8 SEK | -0.28% | +3.16% | +16.18% |
Apr. 25 | Transcript : Bactiguard Holding AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Bactiguard Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Sales forecast by analysts have been recently revised upwards.
Weaknesses
- The company has insufficient levels of profitability.
- One of the major weak points of the company is its financial situation.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+16.18% | 234M | C- | ||
+13.03% | 27.92B | B+ | ||
-29.30% | 3.08B | B- | ||
-14.71% | 2.53B | C+ | ||
+21.58% | 2.47B | - | A- | |
+7.41% | 2.1B | B | ||
-3.87% | 1.91B | - | ||
+0.56% | 1.51B | B | ||
+2.24% | 1.34B | - | ||
+23.78% | 1.24B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BACTI B Stock
- Ratings Bactiguard Holding AB